EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Potassium Iodide Use and Patient Outcomes for Thyroid Storm: An Observational Study

Yuichiro Matsuo iD, Atsushi Miyawaki, Hideaki Watanabe, Hiroki Matsui, Kiyohide Fushimi, Hideo Yasunaga

The Journal of Clinical Endocrinology & Metabolism · 2025

DOI: 10.1210/clinem/dgae187 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Yuichiro Matsuo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, 113-8655, Japan. Hauptthemen laut MEDLINE: Potassium Iodide, Thyroid Crisis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Ministry of Health, Labor, and Welfare of Japan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Iodine, combined with antithyroid drugs, is recommended as an initial pharmacologic treatment for thyroid storm according to some clinical guidelines. However, the clinical efficacy of iodine in managing thyroid storm remains unexplored.

Objective

This study aimed to determine whether early potassium iodide (KI) use is associated with mortality in patients hospitalized for thyroid storm.

Methods

Using the Japanese Diagnosis Procedure Combination database, we identified patients hospitalized with thyroid storm between July 2010 and March 2022. We compared in-hospital mortality, length of stay, and total hospitalization costs between patients who received KI within 2 days of admission (KI group) vs those who did not (non-KI group). Prespecified subgroup analyses were performed based on the presence of the diagnosis of Graves’ disease.

Results

Among 3188 eligible patients, 2350 received KI within 2 days of admission. The crude in-hospital mortality was 6.1% (143/2350) in the KI group and 7.8% (65/838) in the non-KI group. After adjusting for potential confounders, KI use was not significantly associated with in-hospital mortality (odds ratio [OR] for KI use, 0.91; 95% CI, 0.62-1.34). In patients with the diagnosis of Graves’ disease, in-hospital mortality was lower in the KI group than in the non-KI group (OR, 0.46; 95% CI, 0.25-0.88). No significant difference in in-hospital mortality was observed in patients without the diagnosis of Graves’ disease (OR, 1.11; 95% CI, 0.67-1.85). Length of stay was shorter (subdistribution hazard ratio, 1.15; 95% CI, 1.05-1.27), and total hospitalization costs were lower (OR, 0.92; 95% CI, 0.85-1.00) in the KI group compared with the non-KI group.

Conclusion

Our findings suggest that KI may reduce in-hospital mortality among patients hospitalized for thyroid storm with Graves’ disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Potassium IodideThyroid CrisisHumansFemaleMaleHospital MortalityMiddle AgedLength of StayAgedAdultGraves DiseaseJapanHospitalizationTreatment OutcomeRetrospective StudiesAntithyroid AgentsPrognosisFollow-Up Studies

Stichwörter der Autor:innen

Graves’ diseaseobservational studiespotassium iodidethyroid crisis

Substanzen

Potassium IodideAntithyroid Agents

Autor:innen und Institutionen

  • Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, 113-8655, Japan.
  • Department of Health Services Research, Graduate School of Medicine, The University of Tokyo, Tokyo, 113-0033, Japan.
  • Department of Health Policy and Informatics, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, 113-8510, Japan.

ORCID-Profile: Yuichiro Matsuo

Förderung

  • Ministry of Health, Labor, and Welfare of Japan

Zitieren

APA

Matsuo, Y., Miyawaki, A., Watanabe, H., Matsui, H., Fushimi, K., & Yasunaga, H. (2025). Potassium Iodide Use and Patient Outcomes for Thyroid Storm: An Observational Study. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae187

Vancouver

Matsuo Y, Miyawaki A, Watanabe H, Matsui H, Fushimi K, Yasunaga H. Potassium Iodide Use and Patient Outcomes for Thyroid Storm: An Observational Study. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgae187

BibTeX
@article{Matsuo2025,
  author = {Matsuo, Yuichiro and Miyawaki, Atsushi and Watanabe, Hideaki and Matsui, Hiroki and Fushimi, Kiyohide and Yasunaga, Hideo},
  title = {Potassium Iodide Use and Patient Outcomes for Thyroid Storm: An Observational Study},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  doi = {10.1210/clinem/dgae187}
}
Kostenlos starten →